Evaluation of toxicity of aerosols from flavored e-liquids in Sprague-Dawley rats in a 90-day OECD inhalation study, complemented by transcriptomics analysis.


Journal

Archives of toxicology
ISSN: 1432-0738
Titre abrégé: Arch Toxicol
Pays: Germany
ID NLM: 0417615

Informations de publication

Date de publication:
06 2020
Historique:
received: 15 02 2020
accepted: 22 04 2020
pubmed: 6 5 2020
medline: 13 7 2021
entrez: 6 5 2020
Statut: ppublish

Résumé

The use of flavoring substances is an important element in the development of reduced-risk products for adult smokers to increase product acceptance and encourage switching from cigarettes. In a first step towards characterizing the sub-chronic inhalation toxicity of neat flavoring substances, a study was conducted using a mixture of the substances in a base solution of e-liquid, where the standard toxicological endpoints of the nebulized aerosols were supplemented with transcriptomics analysis. The flavor mixture was produced by grouping 178 flavors into 26 distinct chemical groups based on structural similarities and potential metabolic and biological effects. Flavoring substances predicted to show the highest toxicological effect from each group were selected as the flavor group representatives (FGR). Following Organization for Economic Cooperation and Development Testing Guideline 413, rats were exposed to three concentrations of the FGR mixture in an e-liquid composed of nicotine (23 µg/L), propylene glycol (1520 µg/L), and vegetable glycerin (1890 µg/L), while non-flavored and no-nicotine mixtures were included as references to identify potential additive or synergistic effects between nicotine and the flavoring substances. The results indicated that the inhalation of an e-liquid containing the mixture of FGRs caused very minimal local and systemic toxic effects. In particular, there were no remarkable clinical (in-life) observations in flavored e-liquid-exposed rats. The biological effects related to exposure to the mixture of neat FGRs were limited and mainly nicotine-mediated, including changes in hematological and blood chemistry parameters and organ weight. These results indicate no significant additive biological changes following inhalation exposure to the nebulized FGR mixture above the nicotine effects measured in this sub-chronic inhalation study. In a subsequent study, e-liquids with FGR mixtures will be aerosolized by thermal treatment and assessed for toxicity.

Identifiants

pubmed: 32367274
doi: 10.1007/s00204-020-02759-6
pii: 10.1007/s00204-020-02759-6
pmc: PMC7303093
doi:

Substances chimiques

Biomarkers 0
E-Cigarette Vapor 0
Flavoring Agents 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2179-2206

Références

AAALAC (2011) (Association for Assessment and Accreditation of Laboratory Animal Care International): Guide for the care and use of laboratory animals, eighth edition.
Ashakumary L, Vijayammal P (1997) Effect of nicotine on lipoprotein metabolism in rats. Lipids 32:311–315
pubmed: 9076668
Aydos K, Güven M, Can B, Ergün A (2001) Nicotine toxicity to the ultrastructure of the testis in rats. BJU Int 88:622–626
pubmed: 11678761
Baker RR, Massey ED, Smith G (2004a) An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem Toxicol 42(Suppl):S53–83. https://doi.org/10.1016/j.fct.2004.01.001
doi: 10.1016/j.fct.2004.01.001 pubmed: 15072838
Baker RR, Pereira da Silva JR, Smith G (2004b) The effect of tobacco ingredients on smoke chemistry. Part I: Flavourings and additives. Food Chem Toxicol 42(Suppl):S3–37. https://doi.org/10.1016/s0278-6915(03)00189-3
doi: 10.1016/s0278-6915(03)00189-3 pubmed: 15072836
BIOVIA (2014). https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html . Accessed 2014
Burger GT, Renne RA, Sagartz JW, Ayres PH, Coggins CR, Mosberg AT, Hayes AW (1989) Histologic changes in the respiratory tract induced by inhalation of xenobiotics: physiologic adaptation or toxicity? Toxicol Appl Pharmacol 101:521–542
pubmed: 2690398
Carmines EL (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 1: cigarette design, testing approach, and review of results. Food Chem Toxicol 40:77–91
pubmed: 11731038
Carthew P, Clapp C, Gutsell S (2009) Exposure based waiving: the application of the toxicological threshold of concern (TTC) to inhalation exposure for aerosol ingredients in consumer products. Food Chem Toxicol 47:1287–1295
pubmed: 19275927
Chattopadhyay K, Chattopadhyay B (2008) Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein. Indian J Med Res 127:571–576
pubmed: 18765876
Coggins CR, Wagner KA, Werley MS, Oldham MJ (2011) A comprehensive evaluation of the toxicology of cigarette ingredients: carbohydrates and natural products. Inhal Toxicol 23(Suppl 1):13–40. https://doi.org/10.3109/08958378.2011.545085
doi: 10.3109/08958378.2011.545085 pubmed: 21504300
Costigan S, Meredith C (2015) An approach to ingredient screening and toxicological risk assessment of flavours in e-liquids. Regul Toxicol Pharmacol 72:361–369
pubmed: 26026505
Cramer G, Ford R, Hall R (1976) Estimation of toxic hazard—a decision tree approach. Food Cosmet Toxicol 16:255–276
Czerniak R (2001) Gender-based differences in pharmacokinetics in laboratory animal models. Int J Toxicol 20:161–163
pubmed: 11488558
de Oliveira C et al (2014) Obesity and chronic stress are able to desynchronize the temporal pattern of serum levels of leptin and triglycerides. Peptides 51:46–53
pubmed: 24184591
European Chemicals Agency (2014) European Chemicals Agency. https://echa.europa.eu/information-on-chemicals . Accessed 2014
EFSA-Scientific-Committee (2012) Scientific opinion on exploring options for providing advice about possible human health risks based on the concept of threshold of toxicological concern (TTC). EFSA J 10:2750
EU-OSHA (2014). https://oshwiki.eu/wiki/Carcinogenic,_mutagenic,_reprotoxic_(CMR)_substances#Classification . Accessed 2014
European-Commission (2000) commision regulation (EC) No 1565/2000. Off J Eur Commun L180:8–16
European-Commission (2012) Commission implementing regulation (EU) No 872/2012. Off J Eur Union L267:1–161
Everds NE et al (2013) Interpreting stress responses during routine toxicity studies: a review of the biology, impact, and assessment. Toxicol Pathol 41:560–614. https://doi.org/10.1177/0192623312466452
doi: 10.1177/0192623312466452 pubmed: 23475558
Famele M, Ferranti C, Abenavoli C, Palleschi L, Mancinelli R, Draisci R (2015) The chemical components of electronic cigarette cartridges and refill fluids: review of analytical methods. Nicotine Tobacco Res 17:271–279. https://doi.org/10.1093/ntr/ntu197
doi: 10.1093/ntr/ntu197
Faraday MM, Blakeman KH, Grunberg NE (2005) Strain and sex alter effects of stress and nicotine on feeding, body weight, and HPA axis hormones. Pharmacol Biochem Behav 80:577–589
pubmed: 15820527
Gerloff J et al (2017) Inflammatory response and barrier dysfunction by different e-cigarette flavoring chemicals identified by gas chromatography–mass spectrometry in e-liquids and e-vapors on human lung epithelial cells and fibroblasts. Appl In Vitro Toxicol 3:28–40
pubmed: 28337465 pmcid: 28337465
Golechha M (2016) Health promotion methods for smoking prevention and cessation: a comprehensive review of effectiveness and the way forward. Int j Prevent Med 7:7
Goniewicz ML et al (2014) Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco Control 23:133–139
pubmed: 23467656
Ha MA et al (2015) Menthol attenuates respiratory irritation and elevates blood cotinine in cigarette smoke exposed mice. PLoS ONE 10:e0117128
pubmed: 25679525 pmcid: 4334501
Hallagan J (2016) Safety assessment and regulatory authority to use flavors—focus on e-cigarettes and flavored tobacco products
Heck CGMDJ, David JGNRR, Morrissey LBR (1998) Toxicologic evaluation of flavor ingredients added to cigarette tobacco: 13-week inhalation exposures in rats. Inhalation Toxicol 10:357–381
Helen GS, Dempsey DA, Havel CM, Jacob P III, Benowitz NL (2017) Impact of e-liquid flavors on nicotine intake and pharmacology of e-cigarettes. Drug Alcohol Depend 178:391–398
Iranloye B, Bolarinwa A (2009) Effect of nicotine administration on weight and histology of some vital visceral organs in female albino rats. Niger J Physiol Sci 24:7–12
pubmed: 19826458
Iskandar AR et al (2016) A framework for in vitro systems toxicology assessment of e-liquids. Toxicol Mech Methods 26:392–416. https://doi.org/10.3109/15376516.2016.1170251
doi: 10.3109/15376516.2016.1170251 pmcid: 5309872
Kaur G, Muthumalage T, Rahman I (2018) Mechanisms of toxicity and biomarkers of flavoring and flavor enhancing chemicals in emerging tobacco and non-tobacco products. Toxicol Lett 288:143–155
pubmed: 29481849 pmcid: 29481849
Lee K-P, Frame SR, Sykes GP, Valentine R (1993) Testicular degeneration and spermatid retention in young male rats. Toxicol Pathol 21:292–302
pubmed: 8248718
Leigh NJ, Lawton RI, Hershberger PA, Goniewicz ML (2016) Flavourings significantly affect inhalation toxicity of aerosol generated from electronic nicotine delivery systems (ENDS). Tobacco Control 25:81–87
Lisko JG, Tran H, Stanfill SB, Blount BC, Watson CH (2015) Chemical composition and evaluation of nicotine, tobacco alkaloids, pH, and selected flavors in e-cigarette cartridges and refill solutions. Nicotine Tob Res 17:1270–1278
pubmed: 25636907 pmcid: 4573955
Marescotti D et al. (2019) Systems toxicology assessment of a representative e-liquid formulation using human primary bronchial epithelial cells. Toxicol Rep
Matta SG, Fu Y, Valentine JD, Sharp BM (1998) Response of the hypothalamo-pituitary-adrenal axis to nicotine. Psychoneuroendocrinology 23:103–113
pubmed: 9621392
Mendelson JH, Sholar MB, Goletiani N, Siegel AJ, Mello NK (2005) Effects of low-and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology 30:1751–1763
pubmed: 15870834 pmcid: 1383570
Michael B et al (2007) Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices. Toxicol Pathol 35:742–750
pubmed: 17849357
NACLAR (2004) (National Advisory Committee for Laboratory Animal Research): Guidelines on the care and use of animals for scientific purposes.
Nielsen E, Larsen JC (2011) The threshold of toxicological concern (TTC) concept: development and regulatory applications. Danish Ministry of the Enviroment (Environmental Protection Agency),
OECD (1998) OECD test guideline 1: OECD series on principles of good laboratory practice and compliance monitoring organization for economic cooperation and development (OECD) Paris, France
OECD (2009) Test No. 413: subchronic inhalation toxicity: 90-day study. Organization for Economic Cooperation and Development (OECD) Paris, France
Osimitz TG, Droege W, Finch JM (2007) Toxicologic significance of histologic change in the larynx of the rat following inhalation exposure: a critical review. Toxicol Appl Pharmacol 225:229–237
pubmed: 17991503
Oviedo A et al (2016) Evaluation of the tobacco heating system 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke. Regul Toxicol Pharmacol 81:S93–S122
pubmed: 27818348
Oyeyipo I, Raji Y, Emikpe B, Bolarinwa A (2010) Effects of oral administration of nicotine on organ weight, serum testosterone level and testicular histology in adult male rats. Niger J Physiol Sci 25:81–86
pubmed: 22314908
Paschke T, Scherer G, Heller W-D (2002) Effects of ingredients on cigarette smoke composition and biological activity: a literature overview. Beiträge zur Tabakforschung International/Contributions to Tobacco Research 20:107–247
Patil S, Patil S, Bhaktaraj B, Patil SB (1999) Effect of graded doses of nicotine on ovarian and uterine activities in albino rats. Indian J Exp Biol 37:184–186
pubmed: 10641142
Petruccelli G, Verratti V, Antosiewicz J, Cataldi A, Mazzatenta A, Di Giulio C (2010) Reduced pulmonary function is age-dependent in the rat lung in normoxia. Eur J Med Res 15:108
pubmed: 21147635 pmcid: 4360264
Phillips B et al (2015) Toxicity of aerosols of nicotine and pyruvic acid (separate and combined) in Sprague-Dawley rats in a 28-day OECD 412 inhalation study and assessment of systems toxicology. Inhalation Toxicol 27:405–431
Phillips B et al (2017) Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints. Food Chem Toxicol 109:315–332
pubmed: 28882640 pmcid: 28882640
Phillips BW et al (2018) A 90-day OECD TG 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of the aerosol from the carbon heated tobacco product version 1.2 (CHTP1. 2) compared with cigarette smoke. I. Inhalation exposure, clinical pathology and histopathology. Food Chem Toxicol 116:388–413
pubmed: 29654848
REACH (2014) Registration, evaluation, authorisation and restriction of chemicals. https://ec.europa.eu/environment/chemicals/reach/reach_en.htm . Accessed 2014
Renne R et al (1992) 2-Week and 13-week inhalation studies of aerosolized glycerol in rats. Inhalation Toxicol 4:95–111
Rhodes ME, O’Toole SM, Czambel RK, Rubin RT (2001) Male–female differences in rat hypothalamic-pituitary-adrenal axis responses to nicotine stimulation. Brain Res Bull 54:681–688
pubmed: 11403996
Ricart-Jan D, Benavides A, Peinado-Onsurbe J, Llobera M (2002) Immobilization stress alters intermediate metabolism and circulating lipoproteins in the rat. Metab Clin Exp 51:925–931
Roemer E, Tewes F, Meisgen T, Veltel D, Carmines E (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 3: in vitro genotoxicity and cytotoxicity. Food Chem Toxicol 40:105–111
pubmed: 11731040
Rothenberg SJ et al (2000) Lack of effects of nose-only inhalation exposure on testicular toxicity in male rats. Toxicol Sci 53:127–134
pubmed: 10653530
Rustemeier K, Stabbert R, Haussmann H-J, Roemer E, Carmines E (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol 40:93–104
pubmed: 11731039
Schultz T et al (2015) A strategy for structuring and reporting a read-across prediction of toxicity. Regul Toxicol Pharmacol 72:586–601
pubmed: 26003513
SciFinder (2014) https://scifinder.cas.org . Accessed 2014
Sershen H, Reith M, Banay-Schwartz M, Lajtha A (1982) Effects of prenatal administration of nicotine on amino acid pools, protein metabolism, and nicotine binding in the brain. Neurochem Res 7:1515–1522
pubmed: 7170065
Shao XM, Xu B, Liang J, Xie X, Zhu Y, Feldman JL (2012) Nicotine delivery to rats via lung alveolar region-targeted aerosol technology produces blood pharmacokinetics resembling human smoking. Nicotine Tobacco Res 15:1248–1258
Smith R et al (2003) GRAS flavoring substances 21. Food Technol 57:46–53
Soussy S, Ahmad E-H, Baalbaki R, Salman R, Shihadeh A, Saliba NA (2016) Detection of 5-hydroxymethylfurfural and furfural in the aerosol of electronic cigarettes. Tobacco control:tobaccocontrol-2016–053220
The OECD QSAR Toolbox (2014) Organization for economic cooperation and development (OECD). https://www.oecd.org/chemicalsafety/risk-assessment/oecd-qsar-toolbox.htm . Accessed 2014
ToxPlanet (2014) https://www.toxplanet.com/ . Accessed 2014
Vanscheeuwijck P et al (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem Toxicol 40:113–131
pubmed: 11731041
Waldum HL et al (1996) Long-term effects of inhaled nicotine. Life Sci 58:1339–1346
pubmed: 8614291
Werley MS et al (2016) Toxicological assessment of a prototype e-cigaret device and three flavor formulations: a 90-day inhalation study in rats. Inhalation Toxicol 28:22–38
Werley MS, McDonald P, Lilly P, Kirkpatrick D, Wallery J, Byron P, Venitz J (2011) Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology 287:76–90
pubmed: 21683116
Wong ET et al (2016) Evaluation of the tobacco heating system 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke. Regul Toxicol Pharmacol 81:S59–S81
pubmed: 27793746
Yamamoto Y, Tanaka A, Kanamaru A, Tanaka S, Tsubone H, Atoji Y, Suzuki Y (2003) Morphology of aging lung in F344/N rat: alveolar size, connective tissue, and smooth muscle cell markers. The Anatomical Record 272:538–547
pubmed: 12740948

Auteurs

Jenny Ho (J)

PMI S&I, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore, Singapore.

Davide Sciuscio (D)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Ulrike Kogel (U)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Bjoern Titz (B)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Patrice Leroy (P)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Gregory Vuillaume (G)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Marja Talikka (M)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Elyette Martin (E)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Pavel Pospisil (P)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Stefan Lebrun (S)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Wenhao Xia (W)

PMI S&I, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore, Singapore.

Tom Lee (T)

PMI S&I, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore, Singapore.

Yun Xuan Chng (YX)

PMI S&I, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore, Singapore.

Blaine W Phillips (BW)

PMI S&I, Philip Morris International Research Laboratories Pte. Ltd., Science Park II, Singapore, Singapore.

Emilija Veljkovic (E)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Emmanuel Guedj (E)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Yang Xiang (Y)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Nikolai V Ivanov (NV)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Manuel C Peitsch (MC)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Julia Hoeng (J)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Patrick Vanscheeuwijck (P)

PMI S&I, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland. Patrick.Vanscheeuwijck@pmi.com.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH